The policy provides coverage for SI joint denervation for patients diagnosed with chronic sacroiliac joint pain. The new policy went into effect on July 28.
SInergy is a minimally invasive treatment that targets pain generating nerves in the low back and buttock region responsible for sacroiliac joint pain.
More Articles on Pain Management:
Miami’s Center for Regenerative Medicine Introduces Genorthix System for Joint Health
Hollywog Receives FDA Clearance for Back Pain Device
World Congress on Pain to Feature Neuropathic & Cancer Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.